121 Participants Needed

Resilience-Building Intervention for Advance Care Planning

LH
Overseen ByLi-Ting H. Longcoy
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how Chinese Americans in Chicago discuss advance care planning (ACP) with family and religious leaders, particularly when facing cancer, high blood pressure (hypertension), or heart disease. Participants will either complete a survey or participate in an interview to share their experiences. The study seeks to gather insight into people's readiness for these important conversations and the support they might need. Chinese Americans in Chicago, especially those experienced in end-of-life discussions or managing chronic illnesses, may be well-suited for this trial. As an unphased study, this trial offers participants the chance to contribute to valuable cultural insights and enhance support systems for advance care planning.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this resilience-building intervention is safe for advance care planning?

Research has shown that resilience-building activities, especially those that respect cultural differences, are generally easy for people to handle. These activities aim to provide emotional and psychological support without introducing new medications or physical treatments.

Studies on similar activities for Chinese Americans have indicated that these methods help people discuss end-of-life care without causing harm. Reports have not documented any serious side effects or negative outcomes from these activities. The main goal is to improve communication and understanding, which is naturally low-risk.

In summary, current evidence considers the resilience-building activities in this trial safe. Participants can expect to engage in supportive activities and conversations designed to assist them and their families with advance care planning.12345

Why are researchers excited about this trial?

Researchers are excited about this resilience-building intervention for advance care planning because it is culturally tailored specifically for Chinese Americans, a group that often faces unique challenges in end-of-life care discussions. Unlike standard care options that may not address cultural nuances, this intervention aims to enhance communication and decision-making by considering cultural beliefs and practices. By involving not just individuals but also religious leaders and family members, the intervention seeks to provide a holistic approach that could lead to more meaningful and effective advance care planning.

What evidence suggests that this resilience-building intervention is effective for advance care planning?

Research has shown that specially designed programs can increase Chinese Americans' participation in advance care planning (ACP). Studies reveal that fewer than 15% of Chinese Americans complete these plans, compared to 37% of the general U.S. population. This trial will test a culturally tailored resilience-building intervention to close that gap by respecting cultural differences, especially for those with cancer or heart disease. Early results suggest these programs can facilitate more meaningful discussions about ACP for Chinese American families. By focusing on cultural understanding, the program aims to improve communication about end-of-life care.12345

Are You a Good Fit for This Trial?

This trial is for Chinese Americans over 18 with cancer or heart failure who have a family caregiver willing to join the study. Participants must be able to respond in English or Mandarin and have their diagnosis recorded in medical records.

Inclusion Criteria

I have a family member who takes care of me and is willing to join the study.
I am of non-Hispanic Asian descent.
My diagnosis of cancer or heart failure is officially recorded.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Development

Development of a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart disease

Not specified

Usability Testing

Usability test of the resilience-building intervention prototype with 18 pairs of Chinese Americans and their family caregivers

Not specified
1 visit (in-person)

Follow-up

Participants are monitored for acceptability of the intervention immediately after usability testing

Immediate

What Are the Treatments Tested in This Trial?

Interventions

  • Culturally tailored resilience-building intervention
Trial Overview The study aims to develop and test a resilience-building intervention tailored for Chinese Americans, focusing on improving advance care planning discussions among patients with cancer or heart disease and their caregivers.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Group I: Religious LeadersExperimental Treatment1 Intervention
Group II: Chinese Americans with experience in end-of-life care discussionsExperimental Treatment2 Interventions
Group III: Chinese Americans with cancer, hypertension, or heart disease and their family membersExperimental Treatment1 Intervention
Group IV: Chinese Americans living in ChicagoExperimental Treatment1 Intervention

Culturally tailored resilience-building intervention is already approved in United States for the following indications:

🇺🇸
Approved in United States as Culturally Tailored Resilience-Building Intervention for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

Rush University Medical Center

Collaborator

Trials
448
Recruited
247,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

A qualitative study involving 14 Latino patients with advanced cancer and their caregivers identified 13 key end-of-life topics that are crucial for developing culturally sensitive psychosocial interventions.
The most important topics included daily activities, psychosocial support, discussions about diagnosis, and financial difficulties, highlighting the need for tailored support for Latino individuals facing advanced cancer.
Important End-of-Life Topics among Latino Patients and Caregivers Coping with Advanced Cancer.Rosario-Ramos, L., Suarez, K., Peña-Vargas, C., et al.[2022]
A qualitative study involving 14 Latinx advanced cancer patients and 14 caregivers showed that 85.7% reported high acceptance of the CASA psychosocial intervention, indicating its relevance and potential effectiveness for this community.
Participants expressed a strong willingness to engage with the intervention's components, such as communication skills and finding meaning in life, and most supported the inclusion of family caregivers in therapy sessions.
Psychosocial Intervention Cultural Adaptation for Latinx Patients and Caregivers Coping with Advanced Cancer.Torres-Blasco, N., Costas-Muñiz, R., Rosario, L., et al.[2022]
The study successfully adapted the Voicing My CHOiCES (VMC) advance care planning tool for Australian adolescents and young adults (AYAs) with life-limiting illnesses, incorporating feedback from AYAs, healthcare professionals, and parents to enhance its cultural relevance.
Participants confirmed that changes to language, content, and format made the VMC tool more acceptable, highlighting the importance of tailoring advance care planning resources to fit different cultural contexts, even within similar Western societies.
Examining the Cultural Appropriateness of Advance Care Planning Tools for Adolescents and Young Adults With Cancer: An Example of Cross-Cultural Adaptation of the Voicing My CHOiCES Tool.Evans, HE., Jessop, S., Bedoya, SZ., et al.[2023]

Citations

Applying the Multiphase Optimization Strategy ...This study aims to develop a culturally tailored, resilience-building intervention for Chinese Americans with cancer or heart disease.
Building Resilience for Advance Care Planning (ACP) in ...The overall objective of this pilot study is to develop a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart ...
Development of a resilience-building intervention to facilitate ...Development of a resilience-building intervention to facilitate advance care planning between Chinese American patients and their family caregivers.
Development of a Culturally Tailored Resilience-building ...The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure.
Development of a Culturally Tailored Resilience-building ...Less than 15% of Chinese Americans complete advance directives. That is less than half of the 37% completion rate in the US general ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security